Dantrolene suppresses spontaneous Ca2+ release without altering excitation-contraction coupling in cardiomyocytes of

Timothy L Domeier1, Cale J Roberts2, Anne K Gibson2

  • 1Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri; and domeiert@health.missouri.edu.

Insights

Dantrolene prevents spontaneous calcium release in aged hearts without affecting normal heart function. This drug may help prevent age-related cardiac dysfunction by stabilizing calcium handling in cardiomyocytes.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Physiology

Background:

  • Aging impairs cardiomyocyte calcium (Ca2+) homeostasis, affecting sarcoplasmic reticulum (SR) function and cardiac performance.
  • Dantrolene, a ryanodine receptor antagonist, is known to prevent spontaneous Ca2+ release from the SR, suggesting potential antiarrhythmic benefits.

Purpose of the Study:

  • To investigate if dantrolene prevents spontaneous Ca2+ release in aged myocardium.
  • To determine if dantrolene alters excitation-contraction coupling in aged hearts.

Main Methods:

  • Isolated left ventricular cardiomyocytes from young and aged mice were used.
  • Calcium transients and cell shortening were measured using the Ca2+ indicator fluo-4.
  • Experiments involved pacing, isoproterenol stimulation, and Ca2+ overload conditions.

Main Results:

  • Aged cardiomyocytes showed impaired cell shortening despite normal Ca2+ transient amplitudes during pacing.
  • Dantrolene did not affect Ca2+ transients or cell shortening during normal pacing.
  • Under Ca2+ overload, dantrolene increased SR Ca2+ content and Ca2+ wave amplitude in aged, but not young, mice.
  • Dantrolene reduced Ca2+ spark frequency and delayed spontaneous Ca2+ wave onset in aged mice.

Conclusions:

  • Dantrolene attenuates abnormal diastolic Ca2+ release in the aged murine heart.
  • These findings suggest dantrolene may be a therapeutic strategy for preventing age-related cardiac dysfunction.

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
2.2K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
1.2K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K